<DOC>
	<DOC>NCT00978887</DOC>
	<brief_summary>The purpose of the study is to assess the efficacy of Retorna facial cream usage in the reduction or total correction of facial wrinkles. The duration of this double-blind placebo controlled phase 3 clinical trial will be 4 weeks. The estimated number of women to be recruited and randomized for the study is 148. Occurrence of adverse effects will also be evaluated.</brief_summary>
	<brief_title>Retorna Facial Cream in the Treatment of Facial Wrinkles</brief_title>
	<detailed_description />
	<mesh_term>Facies</mesh_term>
	<criteria>Facial wrinkles Signed informed consent Given verbal agreement on solar exposure prevention within hours of intense solar radiation (10 am 4 pm) by the usage of physical protection methods such as umbrellas, caps and hats. Pregnancy Breastfeeding Use of steroids within 6 months. Patients under other experimental treatment Decompensated concomitant diseases Malignant neoplastic conditions. Alcoholism Handicap and/or psychiatric condition preventing treatment accomplishment.</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Facial cream</keyword>
	<keyword>natural product</keyword>
	<keyword>facial wrinkles</keyword>
</DOC>